Redwater Eye Care - Medicare Optometrist in Belle Fourche, SD

Redwater Eye Care is a medicare enrolled "Optometrist" provider in Belle Fourche, South Dakota. Their current practice location is 1432 Mill St, Belle Fourche, South Dakota. You can reach out to their office (for appointments etc.) via phone at (605) 723-3937.

Redwater Eye Care is licensed to practice in South Dakota (license number T624) and it also participates in the medicare program. Redwater Eye Care is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1447664800.

Contact Information

Redwater Eye Care
1432 Mill St,
Belle Fourche, SD 57717-2304
(605) 723-3937
(605) 723-3940



Healthcare Provider's Profile

Full NameRedwater Eye Care
TypeFacility
SpecialityOptometrist
Location1432 Mill St, Belle Fourche, South Dakota
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1447664800
  • Provider Enumeration Date: 06/13/2014
  • Last Update Date: 06/13/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 4385649482
  • Enrollment ID: O20070627000668

Medical Identifiers

Medical identifiers for Redwater Eye Care such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1447664800NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist T624 (South Dakota)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Redwater Eye Care acts as a billing entity for following providers:
Provider NameBrian K Gill
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1285657742
PECOS PAC ID: 8921003005
Enrollment ID: I20070627000685

News Archive

EP-100 membrane-disrupting peptide drug for cancer being tested at TCRS

A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.

Brevetoxin-2 stimulates nerve cell growth and plasticity in cultured mouse neurons

A new study using brevetoxin-2, a compound produced naturally by marine algae, stimulated nerve cell growth and plasticity in cultured mouse neurons. This research advances a potentially new pharmacological treatment to aid recovery of brain function following a stroke or other traumatic brain injury.

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

New grant supports research into diabetic kidney disease and COVID-19

Mater and University of Queensland Researcher Dr Mitchell Sullivan has been awarded a 2020 Advance Queensland Industry Research Fellowship from the Queensland Government to fund his research into diabetic kidney disease and COVID-19.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Redwater Eye Care is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Redwater Eye Care
1432 Mill St,
Belle Fourche, SD 57717-2304

Ph: (605) 723-3937
Redwater Eye Care
1432 Mill St,
Belle Fourche, SD 57717-2304

Ph: (605) 723-3937

News Archive

EP-100 membrane-disrupting peptide drug for cancer being tested at TCRS

A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.

Brevetoxin-2 stimulates nerve cell growth and plasticity in cultured mouse neurons

A new study using brevetoxin-2, a compound produced naturally by marine algae, stimulated nerve cell growth and plasticity in cultured mouse neurons. This research advances a potentially new pharmacological treatment to aid recovery of brain function following a stroke or other traumatic brain injury.

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

New grant supports research into diabetic kidney disease and COVID-19

Mater and University of Queensland Researcher Dr Mitchell Sullivan has been awarded a 2020 Advance Queensland Industry Research Fellowship from the Queensland Government to fund his research into diabetic kidney disease and COVID-19.

Read more News

› Verified 5 days ago


Optometrist in Belle Fourche, SD

Nash Vision Pllc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1830 5th Ave, Belle Fourche, SD 57717
Phone: 605-892-2020    Fax: 605-892-6227
Heidi J Nash, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1830 5th Ave, Belle Fourche, SD 57717
Phone: 605-892-2020    Fax: 605-892-6227
Dr. Brian Keith Gill, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2398 5th Ave Ste 105, Belle Fourche, SD 57717
Phone: 605-723-3937    Fax: 605-723-3940
Black Hills Vision Care
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1830 5th Ave, Belle Fourche, SD 57717
Phone: 605-892-4171    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.